URGN
UroGen Pharma (URGN)
$23
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$41.88
Daily low
$39.50
Price at open
$39.82
52 Week High
$41.88
52 Week Low
$15.04
Market cap
2.0B
Dividend yield
0.00%
Volume
1.3M
Avg. volume
821,172
P/E ratio
-14.60
UroGen Pharma News
Details
Daily high
$41.88
Daily low
$39.50
Price at open
$39.82
52 Week High
$41.88
52 Week Low
$15.04
Market cap
2.0B
Dividend yield
0.00%
Volume
1.3M
Avg. volume
821,172
P/E ratio
-14.60